From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...

Linear scleroderma is a rare skin condition that often affects children and can lead to visible changes in the skin, especially on the forehead. It is a form of localised scleroderma, where a band ...

Researchers found no association between anti-U1RNP autoantibodies and 3-year ILD progression or mortality in patients with ...

Systemic sclerosis (SSc) is a severe autoimmune disease with complex genetic causes. Some genetic contributors have been identified, but others remain ...

Systemic sclerosis (SSc) or scleroderma is a rare, chronic, autoimmune disorder that hardens connective tissue and muscle in ...

In today’s Health headlines, June is National Scleroderma Awareness Month. New research being conducted at Yale seeks to improve risk prediction. And, using AI to ...

RNA-seq and spatial transcriptomics showed immune cell subsets that drive kidney and lung complications in systemic sclerosis ...

Galderma begins 2 new clinical trials to investigate efficacy and safety of nemolizumab to treat patients with systemic sclerosis: Zug, Switzerland Friday, June 27, 2025, 13:00 Hr ...

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company ...

Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients ...